Key facts
- Emy’s last known valuation is $15.4M (Mar 2025).
- It has raised $6.3M; the latest was Later Stage VC ($4.2M) in Mar 2025.
- Notable investors include Bpifrance, UI Investissement, Capital Grand Est, 28DIGITAL, Alsace Business Angels — 15 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 15 names
- ·Watchlist + deal alerts for Emy
- ·The full record, as it builds
Funding rounds
No funding rounds for Emy are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Emy
Developer of medical devices designed to provide perineal rehabilitation for women. The company's devices offer medical guidance through fun exercises to facilitate perineal re-education as to when and how to perform perineum strengthening exercises at home while remaining motivated, enabling women who suffer from urinary leakage to tackle urinary incontinence problems occurring after childbirth or throughout life.
- Sector
- Healthcare
- HQ
- Strasbourg, France
- Founded
- 2017
- Employees
- 26
- Website
- emy.fizimed.com/
- Ownership
- Privately Held (backing)
Emy doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Emy shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Emy in its N-PORT filings yet. We sweep new filings monthly.